Scientists test drug mix in healthy volunteers
NCT ID NCT07134465
Summary
This early-stage study aims to understand how a common antifungal medication (itraconazole) affects the way the body processes a new experimental drug (HSK31858). It involves 24 healthy volunteers who will take both drugs in a specific sequence. The main goal is to measure the levels of the experimental drug in the blood to see if the antifungal changes them, which is important for future safety planning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, China
Conditions
Explore the condition pages connected to this study.